Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

Brain Neoplasms, Malignant, Primary

Interventions

DRUG

Temozolomide

DRUG

Temozolomide

Trial Locations (2)

FLENI Instituto de Rehabilitación y Educación Terapéutica, Belén de Escobar

FLENI Instituto Clínico-Quirúrgico de Diagnóstico y Tratamiento, Ciudad Autónoma de Buenos Aires

All Listed Sponsors

collaborator

FLENI Instituto de Rehabilitación y Educación Terapéutica, BA, Argentina.

UNKNOWN

collaborator

Bioanalytical Unit, Laboratorio Raffo S.A., BA, Argentina.

UNKNOWN

collaborator

FLENI Multi-Specialty Research Center, BA, Argentina.

UNKNOWN

lead

Monte Verde SA

INDUSTRY

NCT02343081 - Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System | Biotech Hunter | Biotech Hunter